Growing community of inventors

Stockholm, Sweden

Hans-Peter Ekre

Average Co-Inventor Count = 4.80

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Hans-Peter EkreUlf Lindahl (2 patents)Hans-Peter EkreErik Yngve Holmer (2 patents)Hans-Peter EkrePer-Olov Eriksson (2 patents)Hans-Peter EkreMats Wahlgren (2 patents)Hans-Peter EkreAnna Leitgeb (2 patents)Hans-Peter EkreStefania Tiddia (1 patent)Hans-Peter EkreLino Liverani (1 patent)Hans-Peter EkreDagmar Pikas (1 patent)Hans-Peter EkreStefania Tidia (0 patent)Hans-Peter EkreHans-Peter Ekre (3 patents)Ulf LindahlUlf Lindahl (6 patents)Erik Yngve HolmerErik Yngve Holmer (4 patents)Per-Olov ErikssonPer-Olov Eriksson (3 patents)Mats WahlgrenMats Wahlgren (3 patents)Anna LeitgebAnna Leitgeb (2 patents)Stefania TiddiaStefania Tiddia (1 patent)Lino LiveraniLino Liverani (1 patent)Dagmar PikasDagmar Pikas (1 patent)Stefania TidiaStefania Tidia (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Dilaforette Ab (2 from 2 patents)

2. Dilafor Ab (1 from 6 patents)

3. Modus Therapeutics Ab (0 patent)


3 patents:

1. 9480701 - Low anticoagulant heparins

2. 9480702 - Use of chemically modified heparin derivates in sickle cell disease

3. 9475888 - Non anti-coagulative glycosaminoglycans comprising repeating disaccharide unit and their medical use

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/12/2025
Loading…